Advances in Radiation Oncology
Scope & Guideline
Connecting Ideas, Advancing Oncology
Introduction
Aims and Scopes
- Clinical and Dosimetric Studies:
The journal consistently publishes research that evaluates clinical outcomes and dosimetric parameters in various cancer treatments, including comparisons between different radiation therapy techniques (e.g., IMRT, proton therapy) and their impacts on patient health. - Innovative Radiation Therapy Techniques:
There is a strong emphasis on innovative approaches such as stereotactic body radiation therapy (SBRT), image-guided radiation therapy (IGRT), and the use of advanced imaging techniques (e.g., MRI-guided therapy) to enhance treatment precision and efficacy. - Integration of Technology in Radiation Oncology:
The journal explores the integration of new technologies, including artificial intelligence (AI), machine learning, and automated treatment planning systems, to streamline processes and improve treatment delivery. - Multidisciplinary Approaches in Cancer Treatment:
Publications often address the collaboration between various specialties, including the integration of systemic therapies, surgical interventions, and palliative care alongside radiation therapy. - Patient-Centered Care and Quality of Life:
Research focusing on patient-reported outcomes, managing treatment-related toxicities, and improving overall quality of life for patients undergoing radiation therapy is a recurring theme.
Trending and Emerging
- Artificial Intelligence and Machine Learning:
There is a growing body of research focusing on the application of AI and machine learning in radiation oncology, particularly in treatment planning, patient stratification, and predictive modeling of treatment outcomes. - Hypofractionated and Ultra-Hypofractionated Therapies:
An increase in studies exploring hypofractionation and ultra-hypofractionation techniques indicates a shift towards more efficient treatment regimens that aim to reduce treatment time while maintaining efficacy. - Patient Experience and Quality of Life Assessments:
Emerging research increasingly emphasizes the importance of patient-reported outcomes and quality of life assessments, reflecting a trend towards more holistic and patient-centered approaches in cancer care. - Combination Therapies with Immunotherapy:
The integration of radiation therapy with immunotherapy is gaining traction, with numerous studies exploring how these modalities can synergize to improve patient outcomes in various cancer types. - Telemedicine and Remote Care Models:
The rise of telemedicine, particularly accelerated by the COVID-19 pandemic, is a new area of focus, with research aimed at understanding its effectiveness and patient acceptance in the context of radiation oncology.
Declining or Waning
- Traditional Fractionation Schedules:
There appears to be a waning interest in traditional fractionation schedules as the field shifts towards hypofractionation and more personalized treatment regimens that optimize patient outcomes. - Conventional Imaging Techniques:
Research centered around conventional imaging methods is decreasing, likely due to advancements in imaging technologies such as MRI and PET that provide more detailed insights into tumor behavior and treatment response. - General Population Studies:
Studies focusing on broad population-level analyses without specific interventions or targeted assessments are becoming less frequent, as there is a stronger push for precision medicine and individualized treatment approaches. - Basic Research on Radiation Biology:
While foundational research remains important, there has been a notable decline in publications dedicated solely to the basic biology of radiation effects, as more emphasis is placed on clinical applications and outcomes. - Single-Institution Studies:
There seems to be a shift away from single-institution studies towards multi-institutional collaborations that provide broader applicability and generalizability of findings.
Similar Journals
MEDICAL PHYSICS
Advancing the Frontiers of Biophysics and MedicineMEDICAL PHYSICS, published by WILEY, stands as a leading journal in the fields of biophysics, medicine, and radiology, boasting an impressive impact factor and classified within the prestigious Q1 category across multiple relevant domains. With its ISSN 0094-2405 and E-ISSN 2473-4209, the journal has been a vital resource since its inception in 1974, leading the discourse well into 2024. Hailing from the United States, MEDICAL PHYSICS serves a diverse academic audience, comprising researchers, clinicians, and students eager to engage with the latest advancements and methodologies. The journal’s authoritative presence is underscored by its Scopus rankings, placing it among the top percentile in both Medicine and Biophysics, marking it as an essential scholarly platform for innovative research and critical reviews. While not currently an Open Access journal, its commitment to curating high-quality articles ensures that readers can access groundbreaking insights into medical imaging, treatment protocols, and the theoretical underpinnings of medical physics. Explore the intersection of technology and healthcare through the esteemed pages of MEDICAL PHYSICS.
Journal of Radiation Research and Applied Sciences
Innovative insights into the effects and applications of radiation.Journal of Radiation Research and Applied Sciences, published by ELSEVIER, is a premier open-access journal since 2013, dedicated to advancing the understanding and application of radiation research in various fields. With an ISSN of 1687-8507, this journal serves as a vital resource for researchers, professionals, and students engaged in the study of the physical and biological effects of radiation, radiation physics, and its applications in medicine and industry. Its rigorous peer-review process ensures the dissemination of high-quality research that meets the growing demands for innovative solutions in radiation science. By offering comprehensive access options, the journal promotes an inclusive approach to sharing knowledge with the global community. The Journal of Radiation Research and Applied Sciences stands out as a key platform for scholarly communication, fostering advancements that impact both theory and practice in the rapidly evolving landscape of radiation research.
Physics & Imaging in Radiation Oncology
Empowering Collaboration in Physics and Imaging for Better Patient CarePhysics & Imaging in Radiation Oncology is a premier journal dedicated to advancing the interdisciplinary field of radiation oncology through innovative research and imaging technologies. Published by Elsevier, this open-access journal has made its mark since its inception in 2017, ensuring that groundbreaking findings are accessible to a broad audience. With a strong focus on the integration of physics, imaging techniques, and oncology, the journal occupies esteemed positions in the academic landscape, ranking in the top quartile for Radiation and Radiology, Nuclear Medicine and Imaging as of 2023. The journal serves as a platform for researchers, professionals, and students to share insights and foster collaboration, ultimately improving patient outcomes through enhanced imaging and treatment modalities. Based in Ireland and operating from Radarweg 29, 1043 NX Amsterdam, Netherlands, the journal aims to bridge the gap between theoretical physics and practical applications in clinical settings.
Journal of Thoracic Oncology
Transforming Knowledge into Practice in Thoracic OncologyJournal of Thoracic Oncology, published by Elsevier Science Inc, is a premier scholarly outlet dedicated to advancing the field of thoracic oncology. With an impressive impact factor and consistently rated in the Q1 quartile across several pertinent categories such as Medicine, Oncology, and Pulmonary and Respiratory Medicine, this journal stands at the forefront of research dissemination. Covering a broad scope that includes innovative therapeutic approaches, clinical trials, and the molecular underpinnings of thoracic malignancies, the journal serves as a vital resource for researchers, healthcare professionals, and students seeking to enhance their understanding of thoracic cancer and its treatment. With publication dates converging from 2006 to 2024, the Journal of Thoracic Oncology fosters a collaborative scholarly community by providing a platform for high-quality research while ensuring accessibility through traditional publication formats. Positioned in the heart of New York City, this journal not only reflects the cutting-edge advancements in oncology but also plays a pivotal role in shaping the future of thoracic cancer care.
STRAHLENTHERAPIE UND ONKOLOGIE
Advancing cancer care through innovative research.STRAHLENTHERAPIE UND ONKOLOGIE is an esteemed journal published by Springer Heidelberg, focusing on critical advancements and research in the fields of Oncology and Radiology. Established in 1986, this journal has carved its niche within the scientific community, ranking in the Q1 category for Radiology, Nuclear Medicine and Imaging, and Q2 for Oncology as of 2023. With an ISSN of 0179-7158 and E-ISSN 1439-099X, it serves as an essential resource for researchers, professionals, and students dedicated to the complexities of cancer treatment and radiation therapy. While the journal operates under a subscription model, its broad international readership values its rigorous peer-review process and comprehensive coverage of pivotal studies. STRAHLENTHERAPIE UND ONKOLOGIE continues to enhance its impact in the domains of oncology and radiology, as evidenced by its commendable Scopus rankings, including a 76th percentile in Radiology and a 65th percentile in Oncology. Its commitment to disseminating innovative research solidifies its role as a cornerstone in the ongoing quest to improve patient care and therapeutic techniques.
Journal of the Egyptian National Cancer Institute
Shaping the future of oncology with impactful findings.Journal of the Egyptian National Cancer Institute, published by SPRINGER, serves as a vital platform for disseminating innovative research in the field of oncology and cancer research. With both ISSN 1110-0362 and E-ISSN 2589-0409, this Open Access journal has been committed to making significant contributions to the scientific community since its inception in 2005. Operating from its base in Egypt, it has established itself as an important resource for researchers, practitioners, and students alike, offering insights into contemporary issues and advancements in cancer care. Recognized in the 2023 category quartiles as Q3 in Cancer Research and Q3 in Oncology, the journal is positioned to impact the ongoing discourse in cancer treatment strategies and health policy. As it continues to publish peer-reviewed articles through available Open Access avenues, the Journal of the Egyptian National Cancer Institute remains dedicated to enhancing the knowledge base and collaborative efforts within the global cancer research community.
RADIOTHERAPY AND ONCOLOGY
Elevating hematology and oncology with impactful research findings.Radiotherapy and Oncology is a leading peer-reviewed journal published by Elsevier Ireland Ltd, focusing on the vital fields of hematology, oncology, and radiology. With an impressive impact factor and ranking in the top quartiles (Q1) of its categories as of 2023, it is recognized for disseminating high-quality research that contributes significantly to advancements in cancer treatment and patient care. The journal, which has been in circulation since 1983, aims to provide a platform for original research articles, reviews, and clinical studies that explore the latest innovations in radiotherapeutic technologies and oncology practices. This journal is essential for researchers, healthcare professionals, and students who are dedicated to improving cancer therapies and outcomes. Although it does not offer open access, the wealth of information contained within its pages supports continued education and development in these crucial medical fields.
Brachytherapy
Advancing the Future of Cancer Treatment and Imaging.Brachytherapy, published by ELSEVIER SCIENCE INC, serves as a pivotal journal in the realms of Oncology and Radiology, Nuclear Medicine, and Imaging. With an ISSN of 1538-4721 and an E-ISSN of 1873-1449, the journal disseminates cutting-edge research and advancements from 2002 to 2024, focusing on the innovative field of brachytherapy. Although classified in the Q3 category for Oncology and Q2 for Radiology, Nuclear Medicine, and Imaging based on the 2023 quartile rankings, it continues to make significant contributions to clinical practice and methodology. Brachytherapy holds a respectable position in Scopus, ranking #155/333 and #234/404 in its respective categories, which reflects its importance and relevance to the scientific community. This journal is indispensable for researchers, healthcare professionals, and students looking to stay abreast of the latest techniques and therapeutic approaches in cancer treatment and imaging practices.
Journal of Radiosurgery and SBRT
Uniting Experts in the Field of RadiosurgeryJournal of Radiosurgery and SBRT is a dedicated platform for advancing the field of radiosurgery and stereotactic body radiation therapy (SBRT), published by OLD CITY PUBLISHING INC. With its ISSN 2156-4639 and E-ISSN 2156-4647, this journal serves researchers and practitioners keen on the latest findings and methodologies in the domains of radiological technology and surgical oncology. Operating from Spain, the journal has established itself within notable quartiles, ranking Q3 in 2023 across categories including Radiological and Ultrasound Technology, Radiology, Nuclear Medicine and Imaging, and Surgery. The journal is indexed in Scopus, with rankings that place it at #311 in Medicine Surgery and #232 in Medicine Radiology categories, reflecting its significance in the academic community. Although it does not currently offer an open-access model, the Journal of Radiosurgery and SBRT aims to foster innovation and collaboration, making it an essential resource for those involved in cutting-edge research and clinical practice in radiosurgery.
Medical Dosimetry
Cultivating Excellence in Radiation Treatment PlanningMedical Dosimetry is a distinguished journal published by Elsevier Science Inc, dedicated to the advancing field of medical dosimetry and its applications within oncology, radiology, and nuclear medicine. With its ISSN 0958-3947 and E-ISSN 1873-4022, this journal serves as a crucial resource for researchers and professionals aiming to enhance their understanding of radiation treatment planning and dosage calculations. Encompassing a comprehensive range of topics from clinical dosimetry to technology assessment, Medical Dosimetry has been disseminating significant findings since its establishment in 1988, contributing to the continuous development of best practices in patient care and safety. The journal currently holds a Q3 ranking in various categories, reflecting its pivotal role in the research community, while not currently offering open access, it remains an essential reference for scholars advancing the techniques utilized in medical imaging and treatment. By fostering a platform for high-quality research, it aims to bridge the gap between theoretical studies and clinical applications, making it a vital addition to any medical library.